Magnetic resonance and fluorescence imaging of doxorubicin-loaded nanoparticles using a novel in vivo model

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 6, Issue 6, 2010, Pages 797-807

  Erten, Ahmet ^a   Wrasidlo, Wolf ^b   Scadeng, Miriam ^c   Esener, Sadik ^a   Hoffman, Robert M ^d,e   Bouvet, Michael ^b,d   Makale, Milan ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e ANTICANCER INC   (United States)

Author keywords

Dorsal skinfold window chamber; MRI; Multifunctional nanoparticle

Indexed keywords

BLUE FLUORESCENCE; COLOCALIZATION; DEEP IMAGING; DOXORUBICIN; DRUG DELIVERY NANOPARTICLE; FLUORESCENCE IMAGING; IN-VIVO; MR IMAGES; MR IMAGING; MRI; MULTIFUNCTIONAL NANOPARTICLE; NON-INVASIVE; OPTICAL IMAGING; ORTHOTOPIC; PANCREATIC TUMORS; PHYSICAL STABILITY; PROOF OF PRINCIPLES; RED FLUORESCENCE; SURFACE DECORATION; WINDOW CHAMBERS;

DEXTRAN; DRUG DELIVERY; FLUORESCENCE; GLUCOSE; IRON OXIDES; LIPOSOMES; NANOMAGNETICS; NANOPARTICLES; PHOSPHOLIPIDS; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; RESONANCE; TUMORS;

MAGNETIC RESONANCE IMAGING;

DEXTRAN; DOXORUBICIN; FERUCARBOTRAN; IRON OXIDE; LIPOSOME; MACROGOL; NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; CROSS LINKING; DRUG DELIVERY SYSTEM; FLUORESCENCE IMAGING; IN VIVO STUDY; LEWIS CARCINOMA; MOLECULAR IMAGING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS TUMOR; PARTICLE SIZE; SKINFOLD; SURFACE PROPERTY;

ANIMALS; CELL LINE, TUMOR; DOXORUBICIN; FLUORESCENCE; HUMANS; LIPOSOMES; MAGNETIC RESONANCE IMAGING; MICE; NANOPARTICLES; NEOPLASMS;

RODENTIA;

EID: 78649844305     PISSN: 15499634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nano.2010.06.005     Document Type: Article

References (32)

1. McCarthy J.R., Weissleder R. Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev 2008, 60:1241-1251.
2. Mikhaylova M., Stasinopoulos I., Kato Y., Artemov D., Bhujwalla Z.M. Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNA. Cancer Gene Ther 2009, 16:217-226.
3. Koenig S.H., Kellar K.E. Theory of 1/T1 and 1/T2 NMRD profiles of solutions of magnetic nanoparticles. Magn Reson Med 1995, 34:227-233.
4. Josephson L., Tung C.H., Moore A., Weissleder R. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem 1999, 10:186-191.
5. Bulte J.W., Hoekstra Y., Kamman R.L., Magin R.L., Webb A.G., Briggs R.W., et al. Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextran-magnetite particles. Magn Reson Med 1992, 25:148-157.
6. Le Duc G., Vander Elst L., Colet J.M., Roch A., Gillis P., Le Bas J.F., et al. Ultrasmall particulate iron oxides as contrast agents for magnetic resonance spectroscopy: a dose-effect study. J Magn Reson Imaging 2001, 13:619-626.
7. Coroiu I. Relaxivities of different superparamagnetic particles for application in NMR tomography. J Magnetism Magn Mater 1999, 201:449-452.
8. Wang Y.X., Hussain S.M., Krestin G.P. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 2001, 11:2319-2331.
9. LaConte L., Nitin N., Bao G. Magnetic nanoparticle probes. Materials Today 2005, 8:32-38.
10. Jung C.W. Surface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging 1995, 13:675-691.
11. Casadei M.A., Cerreto F., Cesa S., Giannuzzo M., Feeney M., Marianecci C., et al. Solid lipid nanoparticles incorporated in dextran hydrogels: a new drug delivery system for oral formulations. Int J Pharm 2006, 325:140-146.
12. Lin Y., Salek M.F.S., Jennings N., Gmitro A.F. An optical imaging system for window chambers in MRI system. SPIE 2008, 6849:684907.1-684907.5.
13. Gaustad J.V., Brurberg K.G., Simonsen T.G., Mollatt C.S., Rofstad E.K. Tumor vascularity assessed by magnetic resonance imaging and intravital microscopy imaging. Neoplasia 2008, 10:354-362.
14. Allen T.M., Hansen C., Martin F., Redemann C., Yau-Young A. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta 1991, 1066:29-36.
15. Klibanov A.L., Maruyama K., Torchilin V.P., Huang L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett 1990, 268:235-237.
16. Senior J., Delgado C., Fisher D., Tilcock C., Gregoriadis G. Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. Biochim Biophys Acta 1991, 1062:77-82.
17. Blume G., Cevc G. Liposomes for the sustained drug release in vivo. Biochim Biophys Acta 1990, 1029:91-97.
18. Woodle M.C., Newman M.S., Cohen J.A. Sterically stabilized liposomes: physical and biological properties. J Drug Target 1994, 2:397-403.
19. Cashion M.P., Long T.E. Biomimetic design and performance of polymerizable lipids. Acc Chem Res 2009, 42:1016-1025.
20. Lopez E., O'Brien D.F., Whitesides T.H. Effects of membrane composition and lipid structure on the photopolymerization of lipid diacetylenes in bilayer membranes. Biochim Biophys Acta 1982, 693:437-443.
21. O'Brien D.F., Klingbiel R.T., Specht D.P., Tyminski P.N. Preparation and characterization of polymerized liposomes. Ann N Y Acad Sci 1985, 446:282-295.
22. Murphy E.A., Majeti B.K., Barnes L.A., Makale M., Weis S.M., Lutu-Fuga K., et al. Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis. Proc Natl Acad Sci U S A 2008, 105:9343-9348.
23. Barbarese E., Ho S.Y., D'Arrigo J.S., Simon R.H. Internalization of microbubbles by tumor cells in vivo and in vitro. J Neuro-Oncol 1995, 26:25-34.
24. Kim I.S., Jeong Y.I., Kim S.H. Self-assembled hydrogel nanoparticles composed of dextran and poly(ethylene glycol) macromer. Int J Pharm 2000, 205:109-116.
25. Endrich B., Asaishi K., Gotz A., Messmer K. Technical report-a new chamber technique for microvascular studies in unanesthetized hamsters. Res Exp Med (Berl) 1980, 177:125-134.
26. Menger M.D., Jager S., Walter P., Hammersen F., Messmer K. A novel technique for studies on the microvasculature of transplanted islets of Langerhans in vivo. Int J Microcirc Clin Exp 1990, 9:103-117.
27. Makale M. Intravital imaging and cell invasion. Methods Enzymol 2007, 426:375-401.
28. Makale M. Chapter 8. Noninvasive imaging of blood vessels. Methods Enzymol 2008, 444:175-199.
29. Katz M.H., Bouvet M., Takimoto S., Spivack D., Moossa A.R., Hoffman R.M., et al. Selective antimetastatic activity of cytosine analog CS-682 in a red fluorescent protein orthotopic model of pancreatic cancer. Cancer Res 2003, 63:5521-5525.
30. Katz M.H., Takimoto S., Spivack D., Moossa A.R., Hoffman R.M., Bouvet M., et al. A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics. J Surg Res 2003, 113:151-160.
31. Katz M.H., et al. Survival efficacy of adjuvant cytosine-analogue CS-682 in a fluorescent orthotopic model of human pancreatic cancer. Cancer Res 2004, 64:1828-1833.
32. Rohrer M., Bauer H., Mintorovitch J., Requardt M., Weinmann H.J. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005, 40:715-724.